Kelyniam Global, Inc. (PINKSHEETS: KLYG), an advanced Engineering and Rapid Prototyping Company specializing in the use of CADCAM technology, announces that Mr. Joseph Delligatti will be taking over as Kelyniam's CEO, and Chairman of the Board of Directors.

Mr. Delligatti was the Director of Sales and Marketing for Stryker Corporation's Physiotherapy Associates Division from September 2005 through July 2007. This Division was sold to a private equity firm in June 2007. While at Stryker Corporation, a 6.7 Billion Dollar Medical Supplier out of Kalamazoo, Michigan, Mr. Delligatti was the U.S. Director of Sales from 1997-1998, National Accounts Manager from 1998-1999, Director of Healthcare Services from 1999-2001, Director of New Business Development from 2001-2005, and Director of Sales and Marketing from 2005-2007.

James Ketner, President and CEO of Kelyniam Global, Inc., stated: "Kelyniam is now positioned to go in a completely different direction than when I started the company back in 2005. It is time for the management to reflect this new direction. As a fellow shareholder, I realize that we are extremely fortunate to have been able to recruit Mr. Delligatti to lead the company in this new direction of medical devises."

Mr. Ketner will remain on the Board of Directors, and will also assume the role of the President of the Engineering Division of Kelyniam Global, Inc.

Mr. Delligatti has a Bachelors of Arts in Psychology and Business from St. John's University, and has attended Harvard Business School Management Program, Harvard Negotiation School Program, Gallup Leadership Training Program, AMA Sales Management Training, SYSTEMA and P.S.S. Sales Training.

Kelyniam Global, Inc. recently posted a video which tells more about the company's new and exciting medical process utilizing CADCAM technology. The video can be watched by going to the company website, and selecting the "Watch our New Medical Video" on Kelyniam's home page, or by following the link www.kelyniam.com/video.wmv.

About Kelyniam Global, Incorporated:

Kelyniam Global, Inc. specializes in the use of CADCAM technology with recent developments in the production of high precision replication of artificial bone implants for medical applications. The company services a vast array of industries such as medical, automotive, aerospace, jewelry, nautical and consumer products.

Please visit our website at www.kelyniam.com for more information.

Contact: Kelyniam Investor Relations at: Buzzbahn Media 6800 Jericho Turnpike Jericho, NY 516-439-4178

Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Kelyniam Global (PK) Charts.
Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Kelyniam Global (PK) Charts.